Top Markets
#1 Derive Derive +33.22%
#2 Cross Cross +20.16%
#3 Geodnet Geodnet +12.50%
#4 Gama Token Gama Token +9.18%
#5 Biconomy Biconomy +9.08%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.14%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +6.82%
#8 The Bitcoin Bull The Bitcoin Bull +6.60%
#9 Cap Cap +6.32%
#10 Based Based +6.22%
Coin of the day
Derive Derive
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Gujarat Terce Laboratories Limited Gujarat Terce Laboratories Limited

Gujarat Terce Laboratories Limited

GUJTERC
Classement en actions #35875
Gujarat Terce Laboratories Ltd. operates as a pharmaceutical enterprise,... Gujarat Terce Laboratories Ltd. operates as a pharmaceutical enterprise, focusing on the production and distribution of various medicinal items. Its comprehensive product range addresses diverse therapeutic areas such as anti-fungal, anti-malarial, and antibiotic treatments, in addition to ayurvedic, cardiovascular, gastrointestinal, gynecological, and respiratory care. The company also offers nutraceuticals, pain relief solutions, and other specialized pharmaceutical products. Mr. N.P. Prajapati founded the company on March 28, 1985, and it is presently based in Ahmedabad, India.
Prix de l'action
$0.42708845
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$3.33M
Changement (1 jour)
4.48%
Changement (1 an)
-9.84%
Pays
IN
Échange Gujarat Terce Laboratories Limited (GUJTERC)

Catégorie

Healthcare
EPS pour Gujarat Terce Laboratories Limited (GUJTERC)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Gujarat Terce Laboratories Limited, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Gujarat Terce Laboratories Limited de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.41 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $0.52 -
US